Human gastric mucins differently regulate helicobacter pylori proliferation, gene expression and interactions with host cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Skoog, Emma C ^a   Sjöling, Åsa ^a   Navabi, Nazanin ^a   Holgersson, Jan ^a   Lundin, Samuel B ^a   Lindén, Sara K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOCONJUGATE; MUCIN 2; MUCIN 5AC; MUCIN 5B; MUCIN 6; STOMACH MUCIN; ADHESIN; BABA PROTEIN, HELICOBACTER PYLORI; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; CYTOKINE; INTERLEUKIN 6; SABA PROTEIN, HELICOBACTER PYLORI;

ARTICLE; BABA GENE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CAGA GENE; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; FLAA GENE; GENE EXPRESSION REGULATION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; HUMAN TISSUE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SABA GENE; SIGNAL TRANSDUCTION; STOMACH GLAND; STOMACH MUCOSA; STOMACH TUMOR; UREA GENE; BACTERIUM ADHERENCE; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENETICS; GLYCOSYLATION; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

ADHESINS, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; CELL LINE, TUMOR; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC MUCINS; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, BACTERIAL; GLYCOSYLATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-6; MICROBIAL VIABILITY; MICROSCOPY, FLUORESCENCE; MUCIN 5AC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84860487998     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036378     Document Type: Article

References (42)

1. Suerbaum S, Michetti P, (2002) Helicobacter pylori infection. N Engl J Med 347: 1175-1186.
2. Fujimoto S, Olaniyi Ojo O, Arnqvist A, Wu JY, Odenbreit S, et al. (2007) Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol 5: 49-58.
3. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M, (2003) Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 56: 287-291.
4. Ishijima N, Suzuki M, Ashida H, Ichikawa Y, Kanegae Y, et al. (2011) BabA-mediated adherence is a potentiator of the Helicobacter pylori Type IV secretion system activity. J Biol Chem.
5. Hessey SJ, Spencer J, Wyatt JI, Sobala G, Rathbone BJ, et al. (1990) Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 31: 134-138.
6. Lindén S, Nordman H, Hedenbro J, Hurtig M, Borén T, et al. (2002) Strain- and blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC glycoforms. Gastroenterology 123: 1923-1930.
7. Linden SK, Wickstrom C, Lindell G, Gilshenan K, Carlstedt I, (2008) Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches. Helicobacter 13: 81-93.
8. Van den Brink GR, Tytgat KM, Van der Hulst RW, Van der Loos CM, Einerhand AW, et al. (2000) H pylori colocalises with MUC5AC in the human stomach. Gut 46: 601-607.
9. Borén T, Falk P, Roth KA, Larson G, Normark S, (1993) Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262: 1892-1895.
10. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, et al. (2002) Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297: 573-578.
11. Linden S, Mahdavi J, Semino-Mora C, Olsen C, Carlstedt I, et al. (2008) Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathog 4: e2.
12. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, et al. (2004) Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305: 1003-1006.
13. Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, et al. (1995) Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 55: 2681-2690.
14. Byrd JC, Yan P, Sternberg L, Yunker CK, Scheiman JM, et al. (1997) Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 113: 455-464.
15. Tsai CJ, Herrera-Goepfert R, Tibshirani RJ, Yang S, Mohar A, et al. (2006) Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. Cancer Epidemiol Biomarkers Prev 15: 272-280.
16. Sakamoto J, Watanabe T, Tokumaru T, Takagi H, Nakazato H, et al. (1989) Expression of Lewisa, Lewisb, Lewisx, Sialyl-Lewisa, and Sialyl-Lewisx Blood Group Antigens in Human Gastric Carcinoma and in Normal Gastric Tissue. Cancer Research 49: 745-752.
17. Cooke CL, An HJ, Kim J, Canfield DR, Torres J, et al. (2009) Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology 137: 1061-1071, e1061-1068.
18. Amado M, Carneiro F, Seixas M, Clausen H, Sobrinho-Simoes M, (1998) Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114: 462-470.
19. Cole SP, Harwood J, Lee R, She R, Guiney DG, (2004) Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol 186: 3124-3132.
20. Jiang X, Doyle MP, (2000) Growth supplements for Helicobacter pylori. J Clin Microbiol 38: 1984-1987.
21. Tu QV, McGuckin MA, Mendz GL, (2008) Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol 57: 795-802.
22. Nakamura N, Ota H, Katsuyama T, Akamatsu T, Ishihara K, et al. (1998) Histochemical reactivity of normal, metaplastic, and neoplastic tissues to alpha-linked N-acetylglucosamine residue-specific monoclonal antibody HIK1083. J Histochem Cytochem 46: 793-801.
23. Nakajima K, Ota H, Zhang MX, Sano K, Honda T, et al. (2003) Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues. J Histochem Cytochem 51: 1689-1698.
24. Linden SK, Sheng YH, Every AL, Miles KM, Skoog EC, et al. (2009) MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy. PLoS Pathog 5: e1000617.
25. Gustafsson A, Sjoblom M, Strindelius L, Johansson T, Fleckenstein T, et al. (2011) Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system. Glycobiology.
26. Holgersson J, Lofling J, (2006) Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity. Glycobiology 16: 584-593.
27. Lofling J, Diswall M, Eriksson S, Boren T, Breimer ME, et al. (2008) Studies of Lewis antigens and H. pylori adhesion in CHO cell lines engineered to express Lewis b determinants. Glycobiology 18: 494-501.
28. Skoog EC, Lindberg M, Linden SK, (2011) Strain-Dependent Proliferation in Response to Human Gastric Mucin and Adhesion Properties of Helicobacter pylori are not Affected by Co-isolated Lactobacillus sp. Helicobacter 16: 9-19.
29. Fox JT, Drouillard JS, Shi X, Nagaraja TG, (2009) Effects of mucin and its carbohydrate constituents on Escherichia coli O157 growth in batch culture fermentations with ruminal or fecal microbial inoculum. J Anim Sci 87: 1304-1313.
30. Park SA, Ko A, Lee NG, (2011) Stimulation of growth of the human gastric pathogen Helicobacter pylori by atmospheric level of oxygen under high carbon dioxide tension. BMC Microbiol 11: 96.
31. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, et al. (2004) Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305: 519-522.
32. Liu J, Weintraub A, Holgersson J, (2003) Multivalent Galalpha1,3Gal-substitution makes recombinant mucin-immunoglobulins efficient absorbers of anti-pig antibodies. Xenotransplantation 10: 149-163.
33. Klein A, Carnoy C, Lamblin G, Roussel P, van Kuik JA, et al. (1993) Isolation and structural characterization of novel sialylated oligosaccharide-alditols from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis. Eur J Biochem 211: 491-500.
34. Odenbreit S, Swoboda K, Barwig I, Ruhl S, Boren T, et al. (2009) Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infection and Immunity 77: 3782-3790.
35. Nordman H, Davies JR, Lindell G, de Bolos C, Real F, et al. (2002) Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution. Biochem J 364: 191-200.
36. Lohmander LS, De Luca S, Nilsson B, Hascall VC, Caputo CB, et al. (1980) Oligosaccharides on proteoglycans from the swarm rat chondrosarcoma. J Biol Chem 255: 6084-6091.
37. Backstrom M, Link T, Olson FJ, Karlsson H, Graham R, et al. (2003) Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. Biochem J 376: 677-686.
38. Herrmann A, Davies JR, Lindell G, Martensson S, Packer NH, et al. (1999) Studies on the "insoluble" glycoprotein complex from human colon. Identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage. J Biol Chem 274: 15828-15836.
39. Wickstrom C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I, (1998) MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem J 334: 685-693.
40. Janzon A, Bhuiyan T, Lundgren A, Qadri F, Svennerholm AM, et al. (2009) Presence of high numbers of transcriptionally active Helicobacter pylori in vomitus from Bangladeshi patients suffering from acute gastroenteritis. Helicobacter 14: 237-247.
41. Linden SK, Driessen KM, McGuckin MA, (2007) Improved in vitro model system for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions. Helicobacter 12: 341-353.
42. Yokozaki H, (2000) Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 50: 767-777.